Literature DB >> 28188997

China's landscape in regenerative medicine.

Xin Tang1, Hua Qin2, Xiaosong Gu3, Xiaobing Fu4.   

Abstract

Regenerative medicine is a burgeoning interdisciplinary research field that can impact healthcare by offering new therapeutic strategies to replace or regenerate human cells, tissues, or organs with the ultimate goal of restoring or establishing normal human functions. The past decade has seen significant progress of regenerative medicine in China, the world's most populous developing country. With government backing, the progress in regenerative medicine is driven by increasing medical demands of people, accompanied by the economic growth, population aging, and lifestyle change in China. Although regenerative medicine encompasses many components, tissue engineering and stem cell technology are generally considered the two key players. In this review article, we outline the representative achievements in the research and application of tissue engineering, stem cell technology, and other regenerative medical strategies attained by various research groups in China, and highlight the major contributions and features of several outstanding studies made by leading Chinese researchers. Where possible, we discuss the unique opportunities and challenges for advancement of regenerative medicine in China. It is our hope that this review will stimulate new research directions for regenerative medicine in general, and encourage strategic collaborations between the east and the west in particular, so that the clinical translation of regenerative medicine can be accelerated to benefit mankind.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  China; Regenerative medicine; Review; Stem cells; Tissue engineering

Mesh:

Year:  2017        PMID: 28188997     DOI: 10.1016/j.biomaterials.2017.01.044

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  5 in total

Review 1.  Stem Cell Research and Clinical Translation: A Roadmap about Good Clinical Practice and Patient Care.

Authors:  Paola Frati; Matteo Scopetti; Alessandro Santurro; Vittorio Gatto; Vittorio Fineschi
Journal:  Stem Cells Int       Date:  2017-09-27       Impact factor: 5.443

2.  Various changes in cryopreserved acellular nerve allografts at -80°C.

Authors:  Yan-Yan Huang; Xiao-Lu Xu; Xi-Jun Huang; Jiang-Hui Liu; Jian Qi; Shuang Zhu; Zhao-Wei Zhu; Bo He; Qing-Tang Zhu; Yang-Bin Xu; Li-Qiang Gu; Xiao-Lin Liu
Journal:  Neural Regen Res       Date:  2018-09       Impact factor: 6.058

3.  Prevascularization promotes endogenous cell-mediated angiogenesis by upregulating the expression of fibrinogen and connective tissue growth factor in tissue-engineered bone grafts.

Authors:  Pengzhen Cheng; Donglin Li; Yi Gao; Tianqing Cao; Huijie Jiang; Jimeng Wang; Junqin Li; Shuaishuai Zhang; Yue Song; Bin Liu; Chunmei Wang; Liu Yang; Guoxian Pei
Journal:  Stem Cell Res Ther       Date:  2018-07-04       Impact factor: 6.832

4.  Comprehensive strategy of conduit guidance combined with VEGF producing Schwann cells accelerates peripheral nerve repair.

Authors:  Ping Wu; Zan Tong; Lihua Luo; Yanan Zhao; Feixiang Chen; Yinping Li; Céline Huselstein; Qifa Ye; Qingsong Ye; Yun Chen
Journal:  Bioact Mater       Date:  2021-03-21

Review 5.  Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia.

Authors:  Fengxuan Han; Jiayuan Wang; Luguang Ding; Yuanbin Hu; Wenquan Li; Zhangqin Yuan; Qianping Guo; Caihong Zhu; Li Yu; Huan Wang; Zhongliang Zhao; Luanluan Jia; Jiaying Li; Yingkang Yu; Weidong Zhang; Genglei Chu; Song Chen; Bin Li
Journal:  Front Bioeng Biotechnol       Date:  2020-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.